A first-of-its-kind national cancer genetic testing program commences this month in the UK. The Stratified Medicine Program, managed by Cancer Research UK, will analyze tumor samples of 9,000 patients with one of six common cancers to customize treatment to the tumor’s genetic composition. Seven hospitals and three laboratories will be involved in testing the samples […]
The Chinese Ministry of Science and Technology (MOST) announced earlier this month that it will invest $244 million in 64 projects in protein research, quantum technology, nanotechnology, development and reproductive biology, stem cells, and Earth science. The funding is part of the sixth year of MOST’s National Major Scientific Research Program, which invested $160 million […]
R&D expenditure in Sweden totaled SEK 113.2 billion ($17.8 billion) in 2010, an increase of 1.4% from 2009. R&D expenditure in the government sector increased 10.1% to SEK 5.5 billion. Government expenditure includes government agency, county council, municipal, and local and regional R&D spending and does not include Agreement on Medical Training and Research funds, […]
A US National Academy of Sciences report suggesting ways for universities to avoid budget cuts should be released by year end. According to Nature, which spoke with some members of the panel preparing the report, researchers may be urged to scrimp by sharing equipment, facilities and management duties with each other and with other research […]
The EPA should set up formal working relationships with other federal organizations in order to improve research about pharmaceuticals and other contaminants in drinking water, according to a US Government Accountability Office (GAO) study published September 8. Although the amounts of pharmaceuticals found in public drinking water systems have been low, generally detected in parts […]
The US Congress will likely approve a new deal for the inspection of overseas drug manufacturing plants, many of which are not routinely FDA inspected. The generic drug industry’s reluctance to pay inspection fees has changed, partly due to the Heparin scandal and the hesitancy of Congress to designate money for inspections. Mylan President Heather […]
Second-quarter 2011 IBO Life Science Index sales grew 8.6%, 5.6% excluding currency, to $3,191.57 million. Operating profit improved 9.8% to $703.35 million, but operating margin declined 200 basis points to 20.8% of sales. Fiscal third-quarter revenue for Becton Dickinson BD Biosciences division improved 9.3%, 4.3% excluding currency, to $337.9 million to make up 17% of […]
London, UK 9/13/11—Abcam, a provider of protein research tools, has agreed to acquire Ascent Scientific for £10 million ($16 million = £0.63 = $1) in cash and £4 million ($6 million) in shares priced at 345.58 pence ($5.48) per share. Ascent is a provider of biochemicals for life science research. For the year ending July […]
Randor, PA 9/2/11—VWR International has acquired INTERNATIONAL P.B.I., an Italian distributor of laboratory supplies and services, with expertise in microbiology. Financial details were not disclosed. The company represents several brands as well as its own and serves many customer segments, including pharmaceutical, chemical, food and beverage, biotechnology, clinical and education. “INTERNATIONAL P.B.I.’s business and strong […]
Rochester, NY 9/1/11—Thermo Fisher Scientific has acquired Intrinsic Bioprobes, a manufacturer of immunoenrichment tools for sample preparation for use in quantitative MS. The company’s Mass Spectrometric Immunoassay (MSIA) technology is designed for the enrichment of low-abundance proteins in biological samples. “The Intrinsic Bioprobes portfolio will enhance Thermo Fisher’s position in the rapidly emerging field of […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
